Studies Show Favorable Results For PARP Inhibitors in the Treatment of Advanced Ovarian Cancer

Dr. Rachel Grisham MSK ovarian cancer section head discussed clinical trials investigating PARP inhibitors for ovarian cancer patients. The event was a round table discussion and interview for Targeted Oncology.…

Continue Reading Studies Show Favorable Results For PARP Inhibitors in the Treatment of Advanced Ovarian Cancer
Dasiglucagon Trial for Congenital Hyperinsulinism Reaches Full Enrollment
source: pixabay.com

Dasiglucagon Trial for Congenital Hyperinsulinism Reaches Full Enrollment

On February 15, 2022, biotechnology company Zealand Pharma A/S (“Zealand”) announced that its Phase 3 1703 clinical trial evaluating dasiglucagon for congenital hyperinsulinism (CHI) had reached full enrollment. Within this…

Continue Reading Dasiglucagon Trial for Congenital Hyperinsulinism Reaches Full Enrollment
Could Prozac Treat Glioblastoma?
source: pixabay.com

Could Prozac Treat Glioblastoma?

Prozac (fluoxetine) is used to treat a variety of mental health conditions including major depressive disorder (MDD), obsessive-compulsive disorder (OCD), bulimia, and premenstrual dysphoric disorder (PMDD), among others. You may…

Continue Reading Could Prozac Treat Glioblastoma?
Study: Orellanine for Patients with Advanced Kidney Cancer
Photo by Robina Weermeijer on Unsplash

Study: Orellanine for Patients with Advanced Kidney Cancer

According to an article recently published in Clinical Trials Arena, the Swedish pharmaceutical company Oncorena has recently initiated a Phase I/II trial for orellanine. This investigational treatment is intended for…

Continue Reading Study: Orellanine for Patients with Advanced Kidney Cancer
Study Finds Blocking Sphingolipids Counteracts Muscular Dystrophy in Mice Models
[Source: pixabay.com]

Study Finds Blocking Sphingolipids Counteracts Muscular Dystrophy in Mice Models

According to a recent article, a research team discovered that the inhibition of sphingolipid synthesis on mice models of Duchenne muscular dystrophy can counteract the certain symptoms of the disease.…

Continue Reading Study Finds Blocking Sphingolipids Counteracts Muscular Dystrophy in Mice Models